Director, U.S. Oncology New Asset Planning

Bristol Myers Squibb • Princeton, NJ

4d • Hybrid

About The Position

The Director, U.S. Oncology New Asset Planning is a senior commercial leader responsible for preparing Bristol Myers Squibb’s U.S. Oncology organization for the successful commercialization of multiple late‑stage and emerging solid tumor assets. This role sits at the critical intersection of Global Development and U.S. Commercial, ensuring early, disciplined, and integrated launch planning well ahead of formal product transitions. The Director will lead U.S. strategic planning for a portfolio of pipeline assets expected to advance toward commercialization beginning in 2027 and beyond. This role will shape how new assets are integrated into the broader U.S. Oncology portfolio, including recommendations on launch team structure, resourcing models, investment prioritization, and functional readiness. As a core member of the U.S. Oncology Marketing Leadership Team, the Director will provide forward‑looking insight, strategic rigor, and enterprise perspective to ensure the organization is positioned to scale effectively as the portfolio expands.

Requirements

• 10+ years experience in U.S. oncology commercial strategy, marketing, or launch planning, ideally with exposure to pipeline or pre‑launch assets.
• Proven ability to operate in ambiguity, synthesize complex inputs, and translate strategy into actionable plans.
• Demonstrated success leading through influence in a highly matrixed organization.
• Strong enterprise mindset with the ability to balance individual asset needs against broader portfolio and organizational priorities.
• Experience contributing to long‑range planning, budget development, and scenario planning.
• Ability to anticipate organizational needs and proactively design solutions ahead of inflection points.
• Bachelor’s degree required

Nice To Haves

• advanced degree (MBA, MS, PhD) preferred

Responsibilities

• Lead U.S. commercial planning for multiple solid tumor pipeline assets transitioning from Global Development toward launch readiness.
• Develop early U.S. commercial hypotheses and strategic considerations (e.g., target populations, positioning considerations, sequencing within the broader portfolio) to inform enterprise decision‑making.
• Partner with Global teams to ensure U.S. commercial needs, realities, and timing are incorporated into development and transition planning.
• Define recommended U.S. launch models for new assets, including go‑to‑market approach, launch team structure, governance, and resourcing strategy.
• Partner with U.S. Oncology leadership to plan organizational implications of upcoming launches, including talent needs, sequencing of launches, and integration into existing brand teams.
• Lead cross‑asset planning to avoid silos and ensure a coordinated, portfolio‑first approach to commercialization.
• Provide U.S. commercial input into long‑range planning, budget development, and functional investment planning for pipeline assets.
• Partner with Finance and cross‑functional stakeholders to align assumptions, scenarios, and timing as assets progress toward launch.
• Support preparation of U.S. Oncology portfolio reviews, long‑range plans, and investment discussions with senior leadership.
• Serve as a key integrator across Marketing, Medical, Market Access, Sales, Forecasting, Finance, and other matrix functions to align early commercialization planning.
• Act as the U.S. Oncology point of accountability for coordinating early commercial discussions across multiple assets simultaneously.
• Establish clear ways of working between Global and U.S. teams to ensure smooth handoffs as assets approach launch.
• Represent new asset planning within the U.S. Oncology Marketing Leadership Team, bringing a forward‑looking, enterprise perspective.
• Support executive communications and leadership updates related to pipeline commercialization readiness and portfolio evolution.
• Build frameworks, tools, and processes that can be reused across assets to enable repeatable, scalable launch planning excellence.

Benefits

• Health Coverage: Medical, pharmacy, dental, and vision care.
• Wellbeing Support: Programs such as BMS Well-Being Account, BMS Living Life Better, and Employee Assistance Programs (EAP).
• Financial Well-being and Protection: 401(k) plan, short- and long-term disability, life insurance, accident insurance, supplemental health insurance, business travel protection, personal liability protection, identity theft benefit, legal support, and survivor support.
• Work-life benefits include: Paid Time Off US Exempt Employees: flexible time off (unlimited, with manager approval, 11 paid national holidays (not applicable to employees in Phoenix, AZ, Puerto Rico or Rayzebio employees) Phoenix, AZ, Puerto Rico and Rayzebio Exempt, Non-Exempt, Hourly Employees: 160 hours annual paid vacation for new hires with manager approval, 11 national holidays, and 3 optional holidays
• Based on eligibility, additional time off for employees may include unlimited paid sick time, up to 2 paid volunteer days per year, summer hours flexibility, leaves of absence for medical, personal, parental, caregiver, bereavement, and military needs and an annual Global Shutdown between Christmas and New Years Day.
• All global employees full and part-time who are actively employed at and paid directly by BMS at the end of the calendar year are eligible to take advantage of the Global Shutdown.

What This Job Offers

• Job Type: Full-time
• Career Level: Director